113 related articles for article (PubMed ID: 21452120)
1. [Infectious complications of biological therapy].
Holub M; Rozsypal H; Chalupa P
Klin Mikrobiol Infekc Lek; 2011 Feb; 17(1):24-9. PubMed ID: 21452120
[TBL] [Abstract][Full Text] [Related]
2. [Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports].
Söderlin M; Blomkvist C; Dahl P; Forsberg P; Fohlman J
Lakartidningen; 2005 Dec 5-11; 102(49):3794-6, 3799-800. PubMed ID: 16408703
[TBL] [Abstract][Full Text] [Related]
3. [Infectious complications due to immunosuppression in organ transplant patients].
Morelon E; Touraine JL
Rev Prat; 2007 Oct; 57(15):1677-86. PubMed ID: 18080426
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-associated infections.
Gea-Banacloche JC
Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.
Morrison VA
Clin Infect Dis; 2014 Nov; 59 Suppl 5():S360-4. PubMed ID: 25352632
[TBL] [Abstract][Full Text] [Related]
6. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic infections and other risks with newer multiple sclerosis therapies.
Berger JR; Houff S
Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841
[TBL] [Abstract][Full Text] [Related]
8. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
9. How to manage infections in the era of biologics?
Saraceno R; Chimenti S
Dermatol Ther; 2008; 21(3):180-6. PubMed ID: 18564248
[TBL] [Abstract][Full Text] [Related]
10. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
11. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases.
Cooper N; Arnold DM
Br J Haematol; 2010 Apr; 149(1):3-13. PubMed ID: 20151975
[TBL] [Abstract][Full Text] [Related]
12. Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.
Strangfeld A; Listing J
Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1181-95. PubMed ID: 17127203
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
Morrison VA
Best Pract Res Clin Haematol; 2010 Mar; 23(1):145-53. PubMed ID: 20620978
[TBL] [Abstract][Full Text] [Related]
14. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
15. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
Lalazar G; Rund D; Shouval D
Br J Haematol; 2007 Mar; 136(5):699-712. PubMed ID: 17338776
[TBL] [Abstract][Full Text] [Related]
16. How to improve the safety of biologic therapy in Crohn's disease.
Ferkolj I
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
[TBL] [Abstract][Full Text] [Related]
17. Viral infection in the renal transplant recipient.
Kotton CN; Fishman JA
J Am Soc Nephrol; 2005 Jun; 16(6):1758-74. PubMed ID: 15829710
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility to infection].
Cerny A
Schweiz Med Wochenschr; 1997 Mar; 127(9):360-6. PubMed ID: 9132935
[TBL] [Abstract][Full Text] [Related]
19. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.
Jain VV; Evans T; Peterson MW
Respir Med; 2006 Jul; 100(7):1291-3. PubMed ID: 16545951
[TBL] [Abstract][Full Text] [Related]
20. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
Winthrop KL
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
